HER2-low Status May Predict Poor Neoadjuvant Chemotherapy Response in HR-negative Breast Cancer: a Real-World Multicenter Study
JAPANESE JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
HER2-low,breast cancer,neoadjuvant chemotherapy,pathological response,prognosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined